# Efficacy and Safety of Sivelestat Sodium and Dexamethasone in the Treatment of ARDS

> **NCT06387823** · NA · RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Acute Respiratory Distress Syndrome

## Interventions

- **DRUG:** Sivelestat sodium
- **DRUG:** Dexamethasone
- **DRUG:** Sivelestat sodium placebo
- **DRUG:** Dexamethasone placebo

## Key facts

- **NCT ID:** NCT06387823
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-15
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-09-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-06-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06387823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06387823, "Efficacy and Safety of Sivelestat Sodium and Dexamethasone in the Treatment of ARDS". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06387823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*